A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies. Conference Paper uri icon

authors

  • Klein, Oliver
  • Kee, Damien
  • Markman, Ben
  • Chang Lee, Rachael
  • Michael, Michael
  • Mileshkin, Linda R
  • Scott, Clare L
  • Linklater, Richelle
  • Menon, Sid
  • Tebbutt, Niall C
  • Palmer, Jodie
  • Behren, Andreas
  • Cebon, Jonathan S

publication date

  • May 20, 2019